Resonance sonomanometry (RSM) for noninvasive, calibration-free continuous blood pressure (BP) measurement using ultrasound imaging.
Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1 – Biotech Investments
EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Miscellaneous Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting